Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #35

    Imponerende 105.000 aktier omsat i dag.... har der været handelsstop?

    1 Reply Last reply
    0
    • K Offline
      K Offline
      Klarussen
      wrote on sidst redigeret af
      #36

      Folk holder vel på aktierne 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #37

        God morgen. 🙂

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #38

          Asien: Fremgang overalt - Hongkong undtagethttps://www.proinvestor.com/investornyt/671711/asien-fremgang-overalt-hongkong-undtaget

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #39

            Onsdagens aviser med Coloplast, Novozymes og Bavarian https://www.proinvestor.com/investornyt/671710/onsdagens-aviser-med-coloplast-novozymes-og-bavarian

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #40

              Amgen's BCMA Bispecific: AMG 701 Enrollment in the Phase 1 study has been paused while we discuss protocol modifications to optimize safety monitoring and mitigation with the FDA. Currently enrolled patients who are demonstrating benefit may continue to receive investigational product and the Company expects to resume patient enrollment in H1 2021. (Teclistamab rival)

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #41

                they are also pausing a CD33 bispecific

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #42

                  "Uptake of KYPROLIS in combination with DARZALEX® (daratumumab) plus dexamethasone (DKd) in the U.S. has been encouraging as reflected in new patient share, and we expect this momentum to continue into 2021 with additional global regulatory approvals of the DKd combination."

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    Klarussen
                    wrote on sidst redigeret af
                    #43

                    Det er godt nok ikke mange Genmab`ber der omsættes de her dage...

                    1 Reply Last reply
                    0
                    • A Offline
                      A Offline
                      AaBforever
                      wrote on sidst redigeret af
                      #44

                      "Der er så stille nu"...måske stilhed før storm:-)

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #45

                        Der er vel ikke forventelige nyheder lige om hjørnet. Så en rolig periode lidt endnu før vi skal se regnskabet og guidance

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #46

                          AbbVie Humira sales $19,8bn..... Good practice run for Epco 😉

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            Gourvin
                            wrote on sidst redigeret af
                            #47

                            Besynderligt dagligt mønster fra Genmab. Starter som lyn og torden. Falder omkring middag, som de fleste danske aktier for så at fortsætte i hullet ved lukkeauktionen!

                            1 Reply Last reply
                            0
                            • A Offline
                              A Offline
                              AaBforever
                              wrote on sidst redigeret af
                              #48

                              ADS US under 40

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #49

                                Genmab
                                @Genmab
                                A recent article published in
                                @berlingske
                                a leading newspaper in Denmark featured Jan van de Winkel, our President and CEO. https://twitter.com/Genmab/status/1357023579267825665

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  Klarussen
                                  wrote on sidst redigeret af
                                  #50

                                  Biogen og Genmab US kursgraferne ligner til forveksling hinanden i dag, Biogen dog nede med 5%, Genmab US kun 1,6% lige nu

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #51

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #52

                                      Asien: Kursfald i takt med drop i amerikanske indeksfutures - NY:
                                      https://www.proinvestor.com/investornyt/671766/asien-kursfald-i-takt-med-drop-i-amerikanske-indeksfutures-ny

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #53

                                        Torsdagens aviser med Novo Nordisk, Ørsted og Ringkjøbing Landbobank: https://www.proinvestor.com/investornyt/671763/torsdagens-aviser-med-novo-nordisk-orsted-og-ringkjobing-landbobank

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #54

                                          Aktier/tendens: Nordea står til belønning på ny regnskabstung dag: https://www.proinvestor.com/investornyt/671776/aktier-tendens-nordea-star-til-belonning-pa-ny-regnskabstung-dag

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger